Primary Ocular Adnexal Lymphoma (POAL) refers to non-Hodgkin lymphoma that originates in the ocular adnexal tissues, which include the eyelids, conjunctiva, lacrimal glands, and orbit (the bony cavity surrounding the eye). It is a rare type of lymphoma that primarily involves the structures surrounding the eye.
Here, we provide an overview of the treatment options available for ocular lymphoma. Please note that the specific treatment plan for your condition will be chosen by your healthcare professional based on your diagnosis and individual circumstances.
Treatment methods
Radiation therapy. Localized radiation therapy is often considered for treating ocular adnexal lymphoma, especially in cases with limited disease involvement.
Chemotherapy. Systemic chemotherapy, which involves the administration of drugs through the bloodstream, may be used for more advanced or widespread cases.
Immunotherapy. Immunotherapeutic approaches, which harness the body's immune system to target cancer cells, are being explored in the treatment of lymphomas.
Surgery. Surgical removal of the tumor may be considered, particularly if the lymphoma is localized and causing significant symptoms.
Watchful waiting. In some cases, especially for slow-growing lymphomas with minimal symptoms, a watchful waiting approach may be adopted, with regular monitoring to assess any changes.
We understand that navigating treatment and diagnosis options can be challenging. The information on this page is meant to give you a general overview of the various approaches. Your healthcare provider will determine specific treatment and diagnostic options based on your individual diagnosis, medical history, and other factors.